1.
Helicobacter pylori -induced gastric inflammation and gastric cancer
by Wang, Fei
Cancer letters, 2013, Vol.345 (2), p.196-202
2.
Review article: the epidemiology and prevention of gastric cancer
by Fock, K. M.
Alimentary pharmacology & therapeutics, 2014-08, Vol.40 (3), p.250-260
3.
The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention
by Lee, Yi-Chia
Gut, 2013-05, Vol.62 (5), p.676-682
4.
Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods
by Ducournau, A
Clinical microbiology and infection, 2016-08, Vol.22 (8), p.715-718
5.
An African origin for the intimate association between humans and Helicobacter pylori
by Manica, Andrea
Nature, 2007-02-22, Vol.445 (7130), p.915-918
6.
7.
Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis
by von Arnim, U.
Alimentary pharmacology & therapeutics, 2016-04, Vol.43 (7), p.825-830
8.
Association between Helicobacter pylori and mortality in the NHANES III study
by Chen, Yu
Gut, 2013-09, Vol.62 (9), p.1262-1269
9.
Epidemiology and clinical characteristics of GERD in the Japanese population
by Fujiwara, Yasuhiro
Journal of gastroenterology, 2009-04-14, Vol.44 (6), p.518-534
10.
Review article: the prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe
by Roberts, S. E.
Alimentary pharmacology & therapeutics, 2016-02, Vol.43 (3), p.334-345
11.
Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis
by Yeh, Jennifer M Jennifer M
Gut, 2015-03-16, Vol.65 (4), p.563-574
12.
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)
by Porras, Carolina
Cancer causes & control, 2013-02-01, Vol.24 (2), p.209-215
13.
Precancerous lesions in the stomach: From biology to clinical patient management
by Rugge, Massimo, M.D., F.A.C.G
Baillière's best practice & research. Clinical gastroenterology, 2013, Vol.27 (2), p.205-223
14.
A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease
by Kim, Tae Jun
Journal of gastroenterology, 2017-04-05, Vol.52 (11), p.1201-1210
15.
Prevalence and risk factors of Helicobacter pylori infection in asymptomatic Chinese children: a prospective, cross‐sectional, population‐based study
by Ding, Z.
Alimentary pharmacology & therapeutics, 2015-10, Vol.42 (8), p.1019-1026
16.
Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China
by Jiang, J
European Journal of Clinical Microbiology and Infectious Diseases, 2016-10-22, Vol.36 (2), p.199-212
17.
Systematic review: the global incidence and prevalence of peptic ulcer disease
by Sung, JJY
Alimentary pharmacology & therapeutics, 2009, Vol.29 (9), p.938-946
18.
Helicobacter pylori therapy: a paradigm shift
by Graham, David Y.
Expert review of anti-infective therapy, 2016-06-02, Vol.14 (6), p.577-585
19.
Helicobacter‐negative gastritis: a distinct entity unrelated to Helicobacter pylori infection
by Genta, R. M.
Alimentary pharmacology & therapeutics, 2015-01, Vol.41 (2), p.218-226
20.
Modifiable factors and esophageal cancer: a systematic review of published meta-analyses
by Castro, Clara
Journal of gastroenterology, 2017-08-18, Vol.53 (1), p.37-51
